What is NNMT and why is it a therapeutic target
Diabetologia 59(11):22982307
pylori) Excessive alcohol consumption Overuse of nonsteroidal anti-inflammatory drugs (NSAIDs) Stress and anxiety Autoimmune disorders Bile reflux As people age, their stomach lining may become thinner, making them more susceptible to gastritis
Research from the STEP and SURMOUNT clinical trials demonstrated that enhancing GLP-1 activity leads to significant, lasting weight reduction when combined with lifestyle modifications
And because the regulatory environment around GLP-1 access is still changing, they track developments like access expansion and the approval of new oral formulations as commercially relevant intelligence rather than background news
In rare cases, switching to Microdose GLP-1 Protocol (starting at $129/mo) may reduce side effects while maintaining therapeutic benefit, though this requires individualized assessment